Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance

Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance

Background: Prostate cancer is the most common cancer in men and second leading cause of cancer-related deaths. Changes in screening guidelines, adoption of active surveillance (AS), and implementation of high-cost technologies have changed treatment costs. Traditional cost-effectiveness studies rel...

Full description

Bibliographic Details
Main Authors: Christopher J. Magnani, Nicolas Bievre, Laurence C. Baker, James D. Brooks, Douglas W. Blayney, Tina Hernandez-Boussard
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:European Urology Open Science
Subjects:
Prostate cancer treatment cost
Active surveillance
High value care
Medicare Fee Schedule
Electronic health records
Calculated cost per day
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320363679

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320363679

Similar Items